Generation of a CRISPR/Cas edited human induced pluripotent stem cell line DHMi005-A-1 carrying a patient-specific disease-causing point mutation in the TBX5 gene

Stem Cell Research - Tập 60 - Trang 102691 - 2022
Harald Lahm1, Paul Heinrich1, Elisabeth Zierler1, Elda Dzilic1, Irina Neb1, Tatjana Luzius1, Stefanie A. Doppler1, Stephanie Schneider2, Rüdiger Lange1,3, Markus Krane3,4, Martina Dreßen1
1Technical University of Munich, School of Medicine & Health, Department of Cardiovascular Surgery, Institute Insure, German Heart Center Munich, Lazarettstrasse 36, 80636 Munich, Germany
2Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital (LMU), Munich, Germany;
3DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
4Division of Cardiac Surgery, Yale University School of Medicine, New Haven, CT, United States

Tài liệu tham khảo

Anzalone, 2019, Search-and-replace genome editing without double-strand breaks or donor DNA, Nature, 576, 149, 10.1038/s41586-019-1711-4 Bangs, 2005, Metaphase chromosome preparation from cultured peripheral blood cells, Curr. Protoc. Human Genet., Chapter 4 Dreßen, 2016, A novel de novo TBX5 mutation in a patient with Holt-Oram syndrome leading to a dramatically reduced biological function, Mol. Genet. Genomic Med., 4, 557, 10.1002/mgg3.234 Moretti, 2010, Patient-specific induced pluripotent stem-cell models for long- QT syndrome, N. Engl. J. Med., 363, 1397, 10.1056/NEJMoa0908679